Literature DB >> 25668732

Management of locally advanced breast cancer-perspectives and future directions.

Konstantinos Tryfonidis1, Elzbieta Senkus2, Maria J Cardoso3, Fatima Cardoso3.   

Abstract

Locally advanced breast cancer (LABC) constitutes a heterogeneous entity that includes advanced-stage primary tumours, cancers with extensive nodal involvement and inflammatory breast carcinomas. Although the definition of LABC can be broadened to include some large operable breast tumours, we use this term to strictly refer to inoperable cancers that are included in the above-mentioned categories. The prognosis of such tumours is often unfavourable; despite aggressive treatment, many patients eventually develop distant metastases and die from the disease. Advances in systemic therapy, including radiation treatment, surgical techniques and the development of new targeted agents have significantly improved clinical outcomes for patients with this disease. Notwithstanding these advances, LABC remains an important clinical problem, particularly in developing countries and those without widely adapted breast cancer awareness programmes. The optimal management of LABC requires a multidisciplinary approach, a well-coordinated treatment schedule and close cooperation between medical, surgical and radiation oncologists. In this Review, we discuss the current state of the art and possible future treatment strategies for patients with LABC.

Entities:  

Mesh:

Year:  2015        PMID: 25668732     DOI: 10.1038/nrclinonc.2015.13

Source DB:  PubMed          Journal:  Nat Rev Clin Oncol        ISSN: 1759-4774            Impact factor:   66.675


  154 in total

1.  Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer.

Authors:  S M Swain; R A Sorace; C S Bagley; D N Danforth; J Bader; M N Wesley; S M Steinberg; M E Lippman
Journal:  Cancer Res       Date:  1987-07-15       Impact factor: 12.701

2.  Postoperative radiotherapy in high-risk postmenopausal breast-cancer patients given adjuvant tamoxifen: Danish Breast Cancer Cooperative Group DBCG 82c randomised trial.

Authors:  M Overgaard; M B Jensen; J Overgaard; P S Hansen; C Rose; M Andersson; C Kamby; M Kjaer; C C Gadeberg; B B Rasmussen; M Blichert-Toft; H T Mouridsen
Journal:  Lancet       Date:  1999-05-15       Impact factor: 79.321

3.  Tumor-infiltrating endothelial cells and endothelial precursor cells in inflammatory breast cancer.

Authors:  Kazuo Shirakawa; Masabumi Shibuya; Yuji Heike; Shigemitsu Takashima; Ichiro Watanabe; Fumio Konishi; Fujio Kasumi; Corey K Goldman; Kenneth A Thomas; Andrew Bett; Masaaki Terada; Hiro Wakasugi
Journal:  Int J Cancer       Date:  2002-05-20       Impact factor: 7.396

4.  Combined chemotherapy-radiotherapy approach in locally advanced (T3b-T4) breast cancer.

Authors:  M De Lena; R Zucali; G Viganotti; P Valagussa; G Bonadonna
Journal:  Cancer Chemother Pharmacol       Date:  1978       Impact factor: 3.333

5.  Recurrent breast cancer following immediate reconstruction with myocutaneous flaps.

Authors:  S A Slavin; S M Love; R M Goldwyn
Journal:  Plast Reconstr Surg       Date:  1994-05       Impact factor: 4.730

6.  Identification and Resection of Clipped Node Decreases the False-negative Rate of Sentinel Lymph Node Surgery in Patients Presenting With Node-positive Breast Cancer (T0-T4, N1-N2) Who Receive Neoadjuvant Chemotherapy: Results From ACOSOG Z1071 (Alliance).

Authors:  Judy C Boughey; Karla V Ballman; Huong T Le-Petross; Linda M McCall; Elizabeth A Mittendorf; Gretchen M Ahrendt; Lee G Wilke; Bret Taback; Eric C Feliberti; Kelly K Hunt
Journal:  Ann Surg       Date:  2016-04       Impact factor: 12.969

Review 7.  Neoadjuvant chemotherapy and targeted therapy in breast cancer: past, present, and future.

Authors:  Simon P Gampenrieder; Gabriel Rinnerthaler; Richard Greil
Journal:  J Oncol       Date:  2013-08-20       Impact factor: 4.375

8.  ESO-ESMO 2nd international consensus guidelines for advanced breast cancer (ABC2)†.

Authors:  F Cardoso; A Costa; L Norton; E Senkus; M Aapro; F André; C H Barrios; J Bergh; L Biganzoli; K L Blackwell; M J Cardoso; T Cufer; N El Saghir; L Fallowfield; D Fenech; P Francis; K Gelmon; S H Giordano; J Gligorov; A Goldhirsch; N Harbeck; N Houssami; C Hudis; B Kaufman; I Krop; S Kyriakides; U N Lin; M Mayer; S D Merjaver; E B Nordström; O Pagani; A Partridge; F Penault-Llorca; M J Piccart; H Rugo; G Sledge; C Thomssen; L Van't Veer; D Vorobiof; C Vrieling; N West; B Xu; E Winer
Journal:  Ann Oncol       Date:  2014-09-18       Impact factor: 32.976

Review 9.  PIK3CA mutations in breast cancer: reconciling findings from preclinical and clinical data.

Authors:  Dimitrios Zardavas; Wayne A Phillips; Sherene Loi
Journal:  Breast Cancer Res       Date:  2014-01-23       Impact factor: 6.466

View more
  45 in total

1.  Corrigendum: Management of locally advanced breast cancer--perspectives and future directions.

Authors:  Konstantinos Tryfonidis; Elzbieta Senkus; Maria J Cardoso; Fatima Cardoso
Journal:  Nat Rev Clin Oncol       Date:  2015-04-14       Impact factor: 66.675

2.  The need for post-mastectomy radiotherapy in patients with IBC.

Authors:  Konstantinos Tryfonidis; Elzbieta Senkus; Maria J Cardoso; Fatima Cardoso
Journal:  Nat Rev Clin Oncol       Date:  2015-04-28       Impact factor: 66.675

3.  The need for post-mastectomy radiotherapy in patients with IBC.

Authors:  Gustavo Ruiz Ares; Eva Ciruelos; Luis Manso
Journal:  Nat Rev Clin Oncol       Date:  2015-04-28       Impact factor: 66.675

Review 4.  Breast cancer complexity: implications of intratumoral heterogeneity in clinical management.

Authors:  Brittany Haynes; Ashapurna Sarma; Pratima Nangia-Makker; Malathy P Shekhar
Journal:  Cancer Metastasis Rev       Date:  2017-09       Impact factor: 9.264

5.  Indian Solutions for Indian Problems-Association of Breast Surgeons of India (ABSI) Practical Consensus Statement, Recommendations, and Guidelines for the Treatment of Breast Cancer in India.

Authors:  S P Somashekhar; Gaurav Agarwal; S V S Deo; P Raghu Ram; Diptendra Sarkar; Vani Parmar
Journal:  Indian J Surg       Date:  2017-06-22       Impact factor: 0.656

6.  Clinical and pathological response to neoadjuvant chemotherapy with different chemotherapy regimens predicts the outcome of locally advanced breast cancer.

Authors:  Shicong Tang; Ke Wang; Kai Zheng; Jiadong Liu; Hengyu Zhang; Mingjian Tan; Hongwan Li; Huimeng Li; Xin Tan; Dequan Liu; Rong Guo
Journal:  Gland Surg       Date:  2020-10

7.  Circulating tumor cells may serve as a supplement to RECIST in neoadjuvant chemotherapy of patients with locally advanced breast cancer.

Authors:  Ji Wang; Xinyang Wang; Rui Chen; Mengdi Liang; Minghui Li; Ge Ma; Tiansong Xia; Shui Wang
Journal:  Int J Clin Oncol       Date:  2022-02-05       Impact factor: 3.402

8.  Reconstruction of the chest wall in locally advanced breast cancer with multi-disciplinary cooperation: a case report of mesh repair plus TRAM combined with DIEP chest wall reconstruction.

Authors:  Shengchao Huang; Pu Qiu; Yuanqi Zhang; Jianwen Li; Weizhang Chen; Baoying Chen; Zhu Liang; Zhongzeng Liang; Kangwei Luo; Baoyi Huang
Journal:  Gland Surg       Date:  2020-08

9.  I-SPY 2: a Neoadjuvant Adaptive Clinical Trial Designed to Improve Outcomes in High-Risk Breast Cancer.

Authors:  Haiyun Wang; Douglas Yee
Journal:  Curr Breast Cancer Rep       Date:  2019-11-20

10.  A phase 2 study of capecitabine and concomitant radiation in women with advanced breast cancer.

Authors:  Wendy A Woodward; Penny Fang; Lisa Arriaga; Hui Gao; Evan N Cohen; James M Reuben; Vicente Valero; Huong Le-Petross; Lavinia P Middleton; Gildy V Babiera; Eric A Strom; Welela Tereffe; Karen Hoffman; Benjamin D Smith; Thomas A Buchholz; George H Perkins
Journal:  Int J Radiat Oncol Biol Phys       Date:  2017-05-03       Impact factor: 8.013

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.